Bimode-M 5mg/500mg Tablet
By Bimode-M
Rx
10 Tablet in a Strip

Composition
Glipizide(5mg) + Metformin(500mg)

Manufacturer - Nucron Pharmaceuticals Pvt Ltd
c-7-b(2), industrial estatebhosari, pune-411026. mh 000000 in

Expires on or after
October, 2025

liver
When using Bimode-M 5mg/500mg Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking this tablet. It is recommended to start with a low dose for those with mild to moderate liver disease. However, the use of Bimode-M 5mg/500mg Tablet is not advised for individuals with severe liver disease. Please consult your doctor for proper guidance before using Bimode-M 5mg/500mg Tablet.

kidney
Bimode-M 5mg/500mg Tablet requires caution in patients with kidney disease as dose adjustment may be necessary. It is not advised for those with severe kidney disease. Regular kidney function tests are recommended while using this medication. Consulting your doctor is important.

alcohol
It is not safe to drink alcohol while taking Bimode-M 5mg/500mg Tablet. Consulting a doctor before consuming alcohol with this medication is advisable.

driving
Do not drive if you are experiencing symptoms of low or high blood sugar while taking Bimode-M 5mg/500mg Tablet, as it may affect your driving ability.

pregnancy
Bimode-M 5mg/500mg Tablet should be avoided during pregnancy as animal studies suggest potential harm to the developing baby. Consult your doctor for a thorough assessment of benefits and risks before using this medication.

breastfeeding
Caution is advised when using Bimode-M 5mg/500mg Tablet during breastfeeding as it is likely unsafe. Limited data indicates a potential risk of the drug passing into breastmilk and causing harm to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹20
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024